Mikhail Blagosklonnys in the Research Anti-aging Using Rapamycin
Mikhail Blagosklonny, a leading researcher in anti-aging and cancer, played a vital role in giving greater prominence to rapamycin in anti-aging research. In the early 80s, it was isolated from a bacterium called Streptomyces hygroscopicus, by thinking it could give some antifungal properties. Initially, it was used for anti-fungal treatments, and later, physicians started using it to reduce the natural reaction of the body towards new kidney transplantation, considering its immune system suppressing properties. In 1999, FDA approved it as a drug for organ transplant patients. In the later years, many researchers suggested the possibilities of extended life using rapamycin.In the 90s, scientists from Sandoz discovered that it could regulate metabolism and growth, and they called the pathway as TOR or target of rapamycin. In the recent years, Blagosklonny researched the various characteristics of rapamycin and revealed a number of facts.
In the early 2000s, he identified that the qualities of rapamycin that is slowing down the tumor growth could also help in anti-aging. Blagosklonny tested himself and identified the benefits of the drug, including its safety. Initially, his findings were rejected by many researchers. But, things started changing when a study by the support of National Institutes of Health in 2009 proved that mice that took rapamycin lived longer. Mice at late middle age showed 9% extended life in the case of the male, and 14% in the case of the female.While some people thought it could worsen the health condition due to the suppression of immune system, a study in 2014 showed that limited dose of rapamycin derivative intake could actually improve the immunity. For people who are concerned with the side effects of the drug, Blagosklonny has an interesting answer. He says that the medicine was approved more than 15 years back, and no serious issues have reported by the use of rapamycin.
Blagosklonny points out that the drug has lesser side effects than aspirin. He also confirmed that whenever he takes the drug, he feels more energized.Mikhail Blagosklonny is currently working as a senior researcher at the Roswell Park Cancer Institute. He is also a professor and philanthropist and looking for ways to offer best cancer treatment options to individuals at an affordable rate. Blagosklonny is an influential researcher and guide who leads his peers and directing his students to expand research keeping the mind in the future. While coming to the cancer treatment, Blagosklonny researches on efficient treatment options that are less expensive than today’s treatment methods. His looks for ways to remove the cancerous cells from the human body without harming any of the healthy cells. Blagosklonny understands that it is highly important while considering the recovery of both body and mind of the patient.Per the latest reports, he advanced significantly in the field that can inspire other researchers to continue with it and complete his hard work. Mikhail Blagosklonny shares a vision of making effective cancer treatment option that is no longer a luxury for people. He has published more than 300 articles, research papers, reviews, and more in various medical journals and collaborated with many journals.